← Back to Clinical Trials
Recruiting NCT05128604

NCT05128604 Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05128604
Status Recruiting
Phase
Sponsor Hospital Universitari de Bellvitge
Condition Endoscopic Surgical Procedure
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2022-05-23
Primary Completion 2026-03-24

Trial Parameters

Condition Endoscopic Surgical Procedure
Sponsor Hospital Universitari de Bellvitge
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-05-23
Completion 2026-03-24
Interventions
Gastroenterostomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is project of help and support for the introduction of the GASTROENTEROANASTOMOSIS technique guided by ENDOSCOPIC -ULTRASOUND (EUS-GE) in centers in Catalonia, facilitating a teacher training. The main objective is facilitate a safe introduction of the technique, limiting technical failures, and if necessary, support in rescue techniques. The goal of this interventional study is to assess the impact of a teaching and on live-support model in the introduction of the gastroenteroanastomosis technique, evaluating its effects in safety and the learning curve. regarding the results in safety and learning curve of for the introduction \[type of study: observational study or clinical trial\] is to \[learn about, test, compare etc.\] in \[describe participant population/health conditions\]. The main question\[s\] it aims to answer are: * \[question 1\] * \[question 2\] Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Eligibility Criteria

Inclusion Criteria: * Age 18 years or more * Gastric outlet obstruction (GOO) caused by passable /unpassable stenosis in the antrum-duodenal region, to malignant or non-malignant conditions * Patient capable of understanding and signing informed consent form * Patient understanding the type of study and complying with the follow-up of complementary tests during the study's duration Exclusion Criteria: * Massive ascites. * Complete stenosis * Failure to sign informed consent form * Patients with intellectual handicap who are unable to understand the nature and possible consequences of the study, unless there is a competent legal representative * Patients unable to adhere to subsequent follow-up requirements * Severe coagulation disorder: INR \> 1.5 not correctible with administration of plasma and/or platelets \< 50,000/mm3

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology